Carbapenem-resistant enterobacteriaceae: A strategic roadmap for infection control
Version 2 2024-06-13, 14:45Version 2 2024-06-13, 14:45
Version 1 2021-10-19, 15:59Version 1 2021-10-19, 15:59
journal contribution
posted on 2024-06-13, 14:45authored byND Friedman, Y Carmeli, AL Walton, MJ Schwaber
The incidence of carbapenem-resistant Enterobacteriaceae (CRE) has increased worldwide with great regional variability. Infections caused by these organisms are associated with crude mortality rates of up to 70%. The spread of CRE in healthcare settings is both an important medical problem and a major global public health threat. All countries are at risk of falling victim to the emergence of CRE; therefore, a preparedness plan is required to avoid the catastrophic natural course of this epidemic. Proactive and adequate preventive measures locally, regionally, and nationally are required to contain the spread of these bacteria. The keys to success in preventing the establishment of CRE endemicity in a region are early detection through targeted laboratory protocols and containment of spread through comprehensive infection control measures. This guideline provides a strategic roadmap for infection control measures based on the best available evidence and expert opinion, to enable preparation of a multifaceted preparedness plan to abort epidemics of CRE.